Press releases related to NextGenNK 2020

First collaboration between partners in the NextGenNK competence center

Avectas and Vycellix Announce Collaboration to Advance Next-Generation Solutions for the Optimized Manufacture of Cell & Gene Therapies. NextGenNK catalyzed interaction among its industrial partners to advance NK cell-based immunotherapies.

Näringslivet sluter upp för utveckling av immunterapi

Tio svenska och internationella företag har nu gemensamt gått ihop med forskare från Karolinska Institutet (KI) för att samverka kring utveckling av nästa generations NK cells-baserade immunterapi mot cancersjukdomar.

New Centre of Excellence at KI for treatment of cancer

Karolinska Institutet is granted funding from Vinnova to start a new centre of excellence. The centre will focus on developing next-generation immunotherapy based on NK-cells for the treatment of cancer.